Alliance Global Partners Initiates Coverage On NeuroSense Therapeutics With Buy Rating, Announces Price Target of $7.5
Alliance Global Partners Initiates Coverage On NeuroSense Therapeutics With Buy Rating, Announces Price Target of $7.5
Alliance Global Partners以买入评级开始对NeuroSense Therapeutics进行报道，宣布目标
Alliance Global Partners analyst James Molloy initiates coverage on NeuroSense Therapeutics (NASDAQ:NRSN) with a Buy rating and announces Price Target of $7.5.
Alliance Global Partners分析师詹姆斯·莫洛伊开始报道NeuroSense Therapeutics（纳斯达克股票代码：NRSN），评级为买入，并宣布目标股价为7.5美元
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间